Search Results - "Heim, Lisanne"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    NFATc1 Promotes Antitumoral Effector Functions and Memory CD8 + T-cell Differentiation during Non-Small Cell Lung Cancer Development by Heim, Lisanne, Friedrich, Juliane, Engelhardt, Marina, Trufa, Denis I, Geppert, Carol I, Rieker, Ralf J, Sirbu, Horia, Finotto, Susetta

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Nuclear factor of activated T cells 1 (NFATc1) is a transcription factor activated by T-cell receptor (TCR) and Ca signaling that affects T-cell activation and…”
    Get full text
    Journal Article
  3. 3

    Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer by Heim, Lisanne, Kachler, Katerina, Siegmund, Raphaela, Trufa, Denis I., Mittler, Susanne, Geppert, Carol-Immanuel, Friedrich, Juliane, Rieker, Ralf J., Sirbu, Horia, Finotto, Susetta

    Published in British journal of cancer (30-04-2019)
    “…Background The immunosuppressive role of the cytokine IL-35 in patients with non-small cell lung cancer (NSCLC) is poorly understood. In this study, we…”
    Get full text
    Journal Article
  4. 4
  5. 5

    ID: 175: The role of STAT3 (Signal Transducer and Activator of Transcription protein-3) in non-small cell lung cancer (NSCLC) by Heim, Lisanne, Finotto, Susetta

    Published in Cytokine (Philadelphia, Pa.) (01-11-2015)
    “…STAT3 is a transcription factor that is activated downstream of several cytokines and growth factors by phosphorylation. It regulates the expression of genes…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Interleukin-10-regulated tumour tolerance in non-small cell lung cancer by Vahl, Julius Malte, Friedrich, Juliane, Mittler, Susanne, Trump, Sonja, Heim, Lisanne, Kachler, Katerina, Balabko, Liubov, Fuhrich, Nicole, Geppert, Carol-Immanuel, Trufa, Denis Iulian, Sopel, Nina, Rieker, Ralf, Sirbu, Horia, Finotto, Susetta

    Published in British journal of cancer (21-11-2017)
    “…Background: Lung cancer is the most life-threatening cancer type worldwide. Treatment options include surgery, radio- and chemotherapy, as well as the use of…”
    Get full text
    Journal Article
  8. 8

    The role of STAT3 (signal transducer and activator of transcription 3) in non-small cell lung cancer (NSCLC) by Heim, Lisanne, Andreev, Katerina, Balabko, Ljubov, Trufa, Denis Iulian, Sirbu, Horia, Hartmann, Arndt, Finotto, Susetta

    Published in The Journal of immunology (1950) (01-05-2016)
    “…Non-small cell lung cancer (NSCLC) is associated with high mortality worldwide underlining the need for novel therapeutic approaches. Signal transducer and…”
    Get full text
    Journal Article
  9. 9

    The role of Signal Transducer and Activator of Transcription protein 5 (STAT5) in non-small cell lung cancer (NSCLC) by Friedrich, Juliane Michaela Margarete M, Heim, Lisanne, Springel, Rebekka, Mittler, Susanne, Gafencu, Dumitrita, Hartmann, Arndt, Sirbu, Horia, Finotto, Susetta

    Published in The Journal of immunology (1950) (01-05-2016)
    “…Signal Transducer and Activator of Transcription protein 5 (STAT5a/b) belongs to a family of T cell transcription factors. The different isoforms of STAT5 are…”
    Get full text
    Journal Article
  10. 10

    STAT1 deficiency supports PD-1/PD-L1 signaling resulting in dysfunctional TNFα mediated immune responses in a model of NSCLC by Friedrich, Juliane, Heim, Lisanne, Trufa, Denis I, Sirbu, Horia, Rieker, Ralf J, Chiriac, Mircea T, Finotto, Susetta

    Published in Oncotarget (14-12-2018)
    “…In this study we described that Signal Transducer and Activator of Transcription 1 (STAT1) is a key point regulator of PD-1 in tumour infiltrating lymphocytes…”
    Get full text
    Journal Article
  11. 11